75F40121P00543

TRADITIONAL NEXT GENERATION SEQUENCING OF WHOLE GENOMES IS DONE IN SHORT 75BP ? 150BP FRAGMENTS. HOWEVER, THESE SHORT READS ARE NOT OPTIMAL FOR DISCOVERING LARGE SCALE GENOMIC CHANGES, AS THEY WILL NOT ALIGN TO THE REFERENCE GENOME USING ESTABLISHED

Research the contractor View USAspending source Save to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

Field	Reported value
Agency	Department of Health and Human Services
Office	FDA OFFICE OF ACQ GRANT SVCS
NAICS	334516 — Analytical Laboratory Instrument Manufacturing
PSC	6640 — Laboratory Equipment and Supplies
Parent award / vehicle	Not reported
Set-aside	NO SET ASIDE USED.
Pricing type	FIRM FIXED PRICE
Obligations	$116.3K
Current contract value	$116.3K
Potential contract value / ceiling	$129.1K
Start date	Sep 16, 2021
Current end date	Aug 24, 2027
Potential end date	Aug 24, 2027
Latest award activity	Jun 16, 2026
Source loaded	Sep 26, 2026

Funding and modification history

Showing the latest 9 of 9 loaded transactions. Negative values are deobligations.

Date	Modification	Obligation change	Description
Jun 16, 2026	P00008	$12.8K	GRIDION SOFTWARE LICENSE & DEVICE WARRANTY AND OLTRAX SOFTWARE LICENSE & DEVICE WARRANTY
Jul 22, 2025	P00007	$12.8K	GRIDION SOFTWARE LICENSE & DEVICE WARRANTY AND OLTRAX SOFTWARE LICENSE & DEVICE WARRANTY
May 31, 2024	P00006	$12.8K	GRIDION SOFTWARE LICENSE & DEVICE WARRANTY AND OLTRAX SOFTWARE LICENSE & DEVICE WARRANTY
Apr 21, 2023	P00005	$12.8K	GRIDION SOFTWARE LICENSE & DEVICE WARRANTY AND OLTRAX SOFTWARE LICENSE & DEVICE WARRANTY
Sep 19, 2022	P00004	$0	GRIDION SOFTWARE LICENSE & DEVICE WARRANTY AND OLTRAX SOFTWARE LICENSE & DEVICE WARRANTY
Apr 5, 2022	P00003	$0	LEASE OF GRIDION MK1 AND VOLTRAX V2
Nov 15, 2021	P00002	$0	EO 14042: LEASE OF GRIDION MK1 AND VOLTRAX V2
Sep 20, 2021	P00001	$0	TO REMOVE CLAUSE 52.225-1, BUY AMERICAN AND INCLUDE THE ADDITIONAL LANGUAGE RELATIVE TO 52.207-5, OPTION TO PURCHASE.
Sep 16, 2021	0	$65.1K	TRADITIONAL NEXT GENERATION SEQUENCING OF WHOLE GENOMES IS DONE IN SHORT 75BP ? 150BP FRAGMENTS. HOWEVER, THESE SHORT READS ARE NOT OPTIMAL FOR DISCOVERING LARGE SCALE GENOMIC CHANGES, AS THEY WILL NOT ALIGN TO THE REFERENCE GENOME USING ESTABLISHED

Estimated positioning window

Oct 25, 2026 – Feb 24, 2027

Recompete signal:

80/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 80/100. Available recorded signals: 75 points.

Contract end 2027-08-24 (303 days from calculation): +35 points
498 historical awards in this buyer and category group: +15 points
9 recorded award transactions: +10 points
Latest award action: 2026-06-16: +5 points
Parent award identifier recorded: +0 points
Solicitation identifier recorded: +10 points
Linked official forecast: +0 points
Calculated on: 2026-10-25 10:18:04.631876+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Oct 25, 2026.

Buyer contacts from matching notices

Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.

Contact	Role	Published contact methods	Evidence	Source date
Brian Wodzisz	Contact	brian.wodzisz@fda.hhs.gov 3017967376	Source	Jul 6, 2021

Research next steps

Check the linked forecast or SAM for a confirmed solicitation and current timing.
Check the stated set-aside against the solicitation and current certifications.
Review the award scope and buyer evidence before making a bid/no-bid decision.